Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.

Andersen S, Richardsen E, Nordby Y, Ness N, Størkersen O, Al-Shibli K, Donnem T, Bertilsson H, Busund LT, Angelsen A, Bremnes RM.

BMC Urol. 2014 Jun 14;14(1):49. doi: 10.1186/1471-2490-14-49.

PMID:
24929427
[PubMed - in process]
Free PMC Article
2.

Stage and tissue-specific prognostic impact of miR-182 in NSCLC.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Busund LT, Bremnes RM.

BMC Cancer. 2014 Feb 27;14:138. doi: 10.1186/1471-2407-14-138.

PMID:
24575749
[PubMed - in process]
Free PMC Article
3.

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Valkov A, Pedersen MI, Busund LT, Bremnes RM.

BMC Clin Pathol. 2014 Feb 13;14(1):9. doi: 10.1186/1472-6890-14-9.

PMID:
24524655
[PubMed]
Free PMC Article
4.

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.

Kilvaer TK, Smeland E, Valkov A, Sorbye SW, Bremnes RM, Busund LT, Donnem T.

BMC Clin Pathol. 2014 Jan 20;14(1):5. doi: 10.1186/1472-6890-14-5.

PMID:
24444363
[PubMed]
Free PMC Article
5.

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

Fassina A, Cappellesso R, Simonato F, Siri M, Ventura L, Tosato F, Busund LT, Pelizzo MR, Fassan M.

Cancer Cytopathol. 2014 Apr;122(4):274-81. doi: 10.1002/cncy.21383. Epub 2013 Dec 10.

PMID:
24327568
[PubMed - indexed for MEDLINE]
6.

Positive prognostic impact of miR-210 in non-small cell lung cancer.

Eilertsen M, Andersen S, Al-Saad S, Richardsen E, Stenvold H, Hald SM, Al-Shibli K, Donnem T, Busund LT, Bremnes RM.

Lung Cancer. 2014 Feb;83(2):272-8. doi: 10.1016/j.lungcan.2013.11.005. Epub 2013 Nov 14.

PMID:
24305009
[PubMed - in process]
7.

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2013 Mar 15;13:9. doi: 10.1186/1472-6890-13-9.

PMID:
23497154
[PubMed]
Free PMC Article
8.

Detection of microRNAs in archival cytology urine smears.

Simonato F, Ventura L, Sartori N, Cappellesso R, Fassan M, Busund LT, Fassina A.

PLoS One. 2013;8(2):e57490. doi: 10.1371/journal.pone.0057490. Epub 2013 Feb 28.

PMID:
23469001
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth.

Hellevik T, Pettersen I, Berg V, Bruun J, Bartnes K, Busund LT, Chalmers A, Bremnes R, Martinez-Zubiaurre I.

Transl Oncol. 2013 Feb;6(1):66-74. Epub 2013 Feb 1.

PMID:
23418618
[PubMed]
Free PMC Article
10.

CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.

Hald SM, Bremnes RM, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Busund LT, Donnem T.

Lung Cancer. 2013 May;80(2):209-15. doi: 10.1016/j.lungcan.2012.12.026. Epub 2013 Feb 4.

PMID:
23384671
[PubMed - indexed for MEDLINE]
11.

Sudden death by an atrial-esophageal fistulae.

Andersen S, Eggen T, Donnem T, Busund LT, Bremnes RM.

J Thorac Oncol. 2013 Feb;8(2):254. doi: 10.1097/JTO.0b013e31827ce3a9. No abstract available.

PMID:
23328552
[PubMed - indexed for MEDLINE]
12.

In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology.

Eilertsen M, Pettersen I, Andersen S, Martinez I, Donnem T, Busund LT, Bremnes RM.

Anticancer Res. 2012 Nov;32(11):4729-36.

PMID:
23155236
[PubMed - indexed for MEDLINE]
13.

Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

PLoS One. 2012;7(10):e47068. doi: 10.1371/journal.pone.0047068. Epub 2012 Oct 5.

PMID:
23071715
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.

Donnem T, Bremnes RM, Busund LT, Andersen S, Pezzella F.

J Thorac Dis. 2012 Apr 1;4(2):212-3. doi: 10.3978/j.issn.2072-1439.2012.03.02. No abstract available.

PMID:
22833829
[PubMed]
Free PMC Article
15.

High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.

Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

Oncoimmunology. 2012 Jan 1;1(1):75-77.

PMID:
22720216
[PubMed]
Free PMC Article
16.

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2012 May 3;12:7. doi: 10.1186/1472-6890-12-7.

PMID:
22554285
[PubMed]
Free PMC Article
17.

Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced.

Hellevik T, Pettersen I, Berg V, Winberg JO, Moe BT, Bartnes K, Paulssen RH, Busund LT, Bremnes R, Chalmers A, Martinez-Zubiaurre I.

Radiat Oncol. 2012 Apr 13;7:59. doi: 10.1186/1748-717X-7-59.

PMID:
22500976
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prognostic impacts of hypoxic markers in soft tissue sarcoma.

Smeland E, Kilvaer TK, Sorbye S, Valkov A, Andersen S, Bremnes RM, Busund LT, Donnem T.

Sarcoma. 2012;2012:541650. doi: 10.1155/2012/541650. Epub 2012 Feb 20.

PMID:
22454562
[PubMed]
Free PMC Article
19.

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2012 Feb 29;12:5. doi: 10.1186/1472-6890-12-5.

PMID:
22375962
[PubMed]
Free PMC Article
20.

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer.

Richardsen E, Uglehus RD, Johnsen SH, Busund LT.

BMC Res Notes. 2012 Feb 21;5:110. doi: 10.1186/1756-0500-5-110.

PMID:
22353218
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk